Since its introduction, in Japan back in 2003 and later in the United States in 2009 as a cholesterol lowering medication called Pitavastatin has garnered attention beyond heart health to potentially aiding in cancer treatment too. Studies have shown results indicating that Pitavastatin might trigger cell death and autophagy particularly targeting types of cancers like triple negative breast cancer and liver cancer. Ability of Pitavastatin to selectively impact cancer cells opens up considering statins, in the realm of cancer therapies – urging researchers to delve deeper into understanding how it works at a level.
Chen, Y.-H., Wu, J.-X., Yang, S.-F., Wu, Y.-C. and Hsiao, Y.-H., 2024. Molecular mechanisms underlying the anticancer properties of pitavastatin against cervical cancer cells. International Journal of Molecular Sciences.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about LIVAMED 1 by Deus Medical, consult with your doctor or healthcare professional.
Chen, Y.-H., Wu, J.-X., Yang, S.-F., Wu, Y.-C. and Hsiao, Y.-H., 2024. Molecular mechanisms underlying the anticancer properties of pitavastatin against cervical cancer cells. International Journal of Molecular Sciences.
Chen, Y.-H., Wu, J.-X., Yang, S.-F., Wu, Y.-C. and Hsiao, Y.-H., 2024. Molecular mechanisms underlying the anticancer properties of pitavastatin against cervical cancer cells. International Journal of Molecular Sciences.
Chen, Y.-H., Wu, J.-X., Yang, S.-F., Wu, Y.-C. and Hsiao, Y.-H., 2024. Molecular mechanisms underlying the anticancer properties of pitavastatin against cervical cancer cells. International Journal of Molecular Sciences.
Home
